Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1985 1
1986 1
1987 2
1988 2
1989 5
1990 2
1992 1
1993 1
1994 2
1995 1
1996 1
1997 5
1998 2
1999 1
2000 5
2001 3
2002 9
2003 7
2004 8
2005 7
2006 6
2007 4
2008 4
2009 7
2010 12
2011 15
2012 13
2013 16
2014 28
2015 25
2016 39
2017 36
2018 35
2019 37
2020 56
2021 93
2022 104
2023 99
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

657 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Nowbar AN, Simader FA, Davies JR, O'Kane PD, Haworth P, Routledge H, Kotecha T, Gamma R, Clesham G, Williams R, Din J, Nijjer SS, Curzen N, Ruparelia N, Sinha M, Dungu JN, Ganesananthan S, Khamis R, Mughal L, Kinnaird T, Petraco R, Spratt JC, Sen S, Sehmi J, Collier DJ, Sohaib A, Keeble TR, Cole GD, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee RK; ORBITA-2 Investigators. Rajkumar CA, et al. N Engl J Med. 2023 Dec 21;389(25):2319-2330. doi: 10.1056/NEJMoa2310610. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 38015442 Free PMC article. Clinical Trial.
At the 12-week follow-up, the mean angina symptom score was 2.9 in the PCI group and 5.6 in the placebo group (odds ratio, 2.21; 95% confidence interval, 1.41 to 3.47; P<0.001). One patient in the placebo group had unacceptable angina leading to unblinding. ...
At the 12-week follow-up, the mean angina symptom score was 2.9 in the PCI group and 5.6 in the placebo group (odds ratio, 2.21; 95% confide …
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, Malik S, Kumar L, Kar S, Singh SK, Upadhye VJ, Iqbal D, Almojam S, Roychoudhury S, Ojha S, Ruokolainen J, Jha NK, Kesari KK. Bhattacharjee R, et al. Crit Rev Oncol Hematol. 2022 Jun;174:103675. doi: 10.1016/j.critrevonc.2022.103675. Epub 2022 Apr 4. Crit Rev Oncol Hematol. 2022. PMID: 35381343 Free article. Review.
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, Oldroyd KG, Motovska Z, Erglis A, Moer R, Hlinomaz O, Jakobsen L, Engstrøm T, Jensen LO, Fallesen CO, Jensen SE, Angerås O, Calais F, Kåregren A, Lauermann J, Mokhtari A, Nilsson J, Persson J, Stalby P, Islam AKMM, Rahman A, Malik F, Choudhury S, Collier T, Pocock SJ, Pernow J. Fröbert O, et al. Circulation. 2021 Nov 2;144(18):1476-1484. doi: 10.1161/CIRCULATIONAHA.121.057042. Epub 2021 Aug 30. Circulation. 2021. PMID: 34459211 Free article. Clinical Trial.
Over the 12-month follow-up, the primary outcome occurred in 67 participants (5.3%) assigned influenza vaccine and 91 participants (7.2%) assigned placebo (hazard ratio, 0.72 [95% CI, 0.52-0.99]; P=0.040). Rates of all-cause death were 2.9% and 4.9% (hazard ratio, 0.59 [95 …
Over the 12-month follow-up, the primary outcome occurred in 67 participants (5.3%) assigned influenza vaccine and 91 participants (7.2%) as …
Literature Commentary.
[No authors listed] [No authors listed] J Neuroophthalmol. 2019 Jun;39(2):273-278. doi: 10.1097/WNO.0000000000000789. J Neuroophthalmol. 2019. PMID: 31094997
Tariq Bhatti, MD and Mark L. Moster, MD will discuss the following 6 articles:1. Gallina P, Savastano A, Becattini E, Orlandini S, Scollato A, Rizzo S, Carreras G, Di Lorenzo N, Porfirio B. ...Ann Neurol. 2018;84:893-904.3. Albrecht P, Jansen A, Lee JI, Moll M, Ring …
Tariq Bhatti, MD and Mark L. Moster, MD will discuss the following 6 articles:1. Gallina P, Savastano A, Becattini E, Orlandini S, Sc …
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
Imperiale TF, Porter K, Zella J, Gagrat ZD, Olson MC, Statz S, Garces J, Lavin PT, Aguilar H, Brinberg D, Berkelhammer C, Kisiel JB, Limburg PJ; BLUE-C Study Investigators. Imperiale TF, et al. N Engl J Med. 2024 Mar 14;390(11):984-993. doi: 10.1056/NEJMoa2310336. N Engl J Med. 2024. PMID: 38477986
As compared with FIT, the next-generation test had superior sensitivity for colorectal cancer (P<0.001) and for advanced precancerous lesions (P<0.001) but had lower specificity for advanced neoplasia (P<0.001). ...
As compared with FIT, the next-generation test had superior sensitivity for colorectal cancer (P<0.001) and for advanced precancer …
Diabetic somatic neuropathies.
Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Boulton AJ, et al. Diabetes Care. 2004 Jun;27(6):1458-86. doi: 10.2337/diacare.27.6.1458. Diabetes Care. 2004. PMID: 15161806 Review. No abstract available.
One-Step Synthesis of a Binder-Free, Stable, and High-Performance Electrode; Cu-O|Cu(3)P Heterostructure for the Electrocatalytic Methanol Oxidation Reaction (MOR).
Yarmolenko A, Malik B, Avraham ES, Nessim GD. Yarmolenko A, et al. Nanomaterials (Basel). 2023 Mar 30;13(7):1234. doi: 10.3390/nano13071234. Nanomaterials (Basel). 2023. PMID: 37049328 Free PMC article.
High-resolution transmission electron microscopy analysis revealed the formation of 3D nanocrystals with defects and pores. Cu-O|Cu(3)P outperformed the MOR activity of individual Cu(3)P and Cu-O owing to the synergistic interaction between them. Cu(3) …
High-resolution transmission electron microscopy analysis revealed the formation of 3D nanocrystals with defects and pores. Cu-O|Cu(3 …
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia.
Ehtewish H, Mesleh A, Ponirakis G, De la Fuente A, Parray A, Bensmail I, Abdesselem H, Ramadan M, Khan S, Chandran M, Ayadathil R, Elsotouhy A, Own A, Al Hamad H, Abdelalim EM, Decock J, Alajez NM, Albagha O, Thornalley PJ, Arredouani A, Malik RA, El-Agnaf OMA. Ehtewish H, et al. Int J Mol Sci. 2023 May 1;24(9):8117. doi: 10.3390/ijms24098117. Int J Mol Sci. 2023. PMID: 37175824 Free PMC article.
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial.
Pabon M, Cunningham J, Claggett B, Felker GM, McMurray JJV, Metra M, Diaz R, Wang X, Arias-Mendoza A, Bonderman D, Crespo-Leiro M, Fonseca C, Goncalvesova E, Lund M, O'Meara E, Sliwa-Hahnle K, Malik FI, Solomon SD, Teerlink JR; GALACTIC-HF Investigators. Pabon M, et al. JACC Heart Fail. 2023 Dec;11(12):1729-1738. doi: 10.1016/j.jchf.2023.07.029. Epub 2023 Oct 11. JACC Heart Fail. 2023. PMID: 37831045 Clinical Trial.
Sex did not significantly modify omecamtiv mecarbil's treatment effect (P interaction = 0.68). Women also had 20% less risk of cardiovascular death, heart failure event, and all-cause death. ...
Sex did not significantly modify omecamtiv mecarbil's treatment effect (P interaction = 0.68). Women also had 20% less risk of cardio …
Advances in nanocarbon composite materials.
Malik S, Krasheninnikov AV, Marchesan S. Malik S, et al. Beilstein J Nanotechnol. 2018 Jan 3;9:20-21. doi: 10.3762/bjnano.9.3. eCollection 2018. Beilstein J Nanotechnol. 2018. PMID: 29379696 Free PMC article. No abstract available.
657 results